chr17-78124785-C-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001127198.5(TMC6):​c.634-4G>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000701 in 1,427,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.0e-7 ( 0 hom. )

Consequence

TMC6
NM_001127198.5 splice_region, intron

Scores

2
Splicing: ADA: 0.00001421
2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.15

Publications

0 publications found
Variant links:
Genes affected
TMC6 (HGNC:18021): (transmembrane channel like 6) Epidermodysplasia verruciformis (EV) is an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. EV is caused by mutations in either of two adjacent genes located on chromosome 17q25.3. Both of these genes encode integral membrane proteins that localize to the endoplasmic reticulum and are predicted to form transmembrane channels. This gene encodes a transmembrane channel-like protein with 10 transmembrane domains and 2 leucine zipper motifs. [provided by RefSeq, Jul 2008]
TMC6 Gene-Disease associations (from GenCC):
  • epidermodysplasia verruciformis, susceptibility to, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • epidermodysplasia verruciformis
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMC6NM_001127198.5 linkc.634-4G>C splice_region_variant, intron_variant Intron 7 of 19 ENST00000590602.6 NP_001120670.1 Q7Z403-1A0A024R8V2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMC6ENST00000590602.6 linkc.634-4G>C splice_region_variant, intron_variant Intron 7 of 19 2 NM_001127198.5 ENSP00000465261.1 Q7Z403-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
7.01e-7
AC:
1
AN:
1427398
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
707266
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32786
American (AMR)
AF:
0.00
AC:
0
AN:
39050
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25526
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37780
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82466
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49680
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5390
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1095644
Other (OTH)
AF:
0.0000169
AC:
1
AN:
59076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.030
DANN
Benign
0.69
PhyloP100
-1.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000014
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs376851783; hg19: chr17-76120866; API